Cited by 848Cardiac electrophysiology and arrhythmiasIon channel regulation and functionCardiovascular Effects of Exercise

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

Brugada, Ramon, Hong, Kui, Dumaine, Robert, Cordeiro, Jonathan, Gaita, Fiorenzo, Borggrefe, Martin, Menendez, Teresa M., Brugada, Josep, Pollevick, Guido D., Wolpert, Christian, Burashnikov, Elena, Matsuo, Kiyotaka, Sheng Wu, Yue, Guerchicoff, Alejandra, Bianchi, Francesca, Giustetto, Carla, Schimpf, Rainer, Brugada, Pedro, Antzelevitch, Charles·2004·Circulation

DOI 10.1161/01.cir.0000109482.92774.3a

Open this paper in CoChat — free account

Abstract

BACKGROUND: Sudden cardiac death takes the lives of more than 300 000 Americans annually. Malignant ventricular arrhythmias occurring in individuals with structurally normal hearts account for a subgroup of these sudden deaths. The present study describes the genetic basis for a new clinical entity characterized by sudden death and short-QT intervals in the ECG. METHODS AND RESULTS: Three families with hereditary short-QT syndrome and a high incidence of ventricular arrhythmias and sudden cardiac death were studied. In 2 of them, we identified 2 different missense mutations resulting in the same amino acid change (N588K) in the S5-P loop region of the cardiac IKr channel HERG (KCNH2). The mutations dramatically increase IKr, leading to heterogeneous abbreviation of action potential duration and refractoriness, and reduce the affinity of the channels to IKr blockers. CONCLUSIONS: We demonstrate a novel genetic and biophysical mechanism responsible for sudden death in infants, children, and young adults caused by mutations in KCNH2. The occurrence of sudden cardiac death in the first 12 months of life in 2 patients suggests the possibility of a link between KCNH2 gain of function mutations and sudden infant death syndrome. KCNH2 is the binding target for a wide spectrum of cardiac and noncardiac pharmacological compounds. Our findings may provide better understanding of drug interaction with KCNH2 and have implications for diagnosis and therapy of this and other arrhythmogenic diseases.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000109482.92774.3a

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sudden cardiac death
Zipes, D. P., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.21.2334 · Cited by 2,744
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincent, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,253
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation
Chen, Q., Kirsch, G. E., Zhang, D., Brugada, R., Brugada, J., Brugada, P., Potenza, D. R., Moya‐Mitjans, À., Borggrefe, M., BREITHARDT, G. E., et al. (1998) · Nature · doi:10.1038/32675 · Cited by 1,823
Two components of cardiac delayed rectifier K+ current. Differential sensitivity to block by class III antiarrhythmic agents.
Sanguinetti, M. C., & Jurkiewicz, N. K. (1990) · The Journal of General Physiology · doi:10.1085/jgp.96.1.195 · Cited by 1,462
KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation
Chen, Y.-H., Xu, S.-J., Bendahhou, S., Wang, X.-L., Wang, Y., Xu, W.-Y., Jin, H., Sun, H., Su, X.-Y., Zhuang, Q.-N., et al. (2003) · Science · doi:10.1126/science.1077771 · Cited by 989
Short QT Syndrome: A Familial Cause of Sudden Death
Gaita, F., Giustetto, C., Bianchi, F., Wolpert, C., Schimpf, R., Riccardi, R., Grossi, S., Richiardi, E., & Borggrefe, M. (2003) · Circulation · doi:10.1161/01.cir.0000085071.28695.c4 · Cited by 708
Self-citation
Idiopathic Short QT Interval:A New Clinical Syndrome?
Gussak, I. B., Brugada, P., Brugada, J., Wright, R. S., Kopecky, S. L., CHAITMAN, B. R., & Bjerregaard, P. (2000) · Cardiology · doi:10.1159/000047299 · Cited by 669
Multiple Mechanisms in the Long-QT Syndrome
Roden, D. M., Lazzara, R., Rosen, M. R., Schwartz, P. J., Towbin, J. A., & Vincent, G. M. (1996) · Circulation · doi:10.1161/01.cir.94.8.1996 · Cited by 631
NovelSCN5AMutation Leading Either to Isolated Cardiac Conduction Defect or Brugada Syndrome in a Large French Family
Kyndt, F., Probst, V., Potet, F., Demolombe, S., Chevallier, J.-C., Baró, I., Moisan, J., Boisseau, P., Schott, J., Escande, D., et al. (2001) · Circulation · doi:10.1161/hc5001.100834 · Cited by 363
HERG, a Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine
Roy, M. L., Dumaine, R., & Brown, A. M. (1996) · Circulation · doi:10.1161/01.cir.94.4.817 · Cited by 302

Show all 27 references

Research works printed but not linked: 8

10.1161/circ.98.21.2334 · DOI
10.1161/circ.94.8.1996 · DOI
10.1161/circ.104.25.3081 · DOI
1998, J Pharmacol Exp Ther, 286, 727
10.1161/circ.94.4.817 · DOI
2000, Mol Pharmacol, 57, 367
10.1161/res.82.3.386 · DOI
10.1161/res.87.11.1012 · DOI

Sorted by citations

Items 201–300 of 848

Sudden Cardiac Arrest Without Overt Heart Disease
Modi, S. S., & Krahn, A. D. (2011) · Circulation · doi:10.1161/circulationaha.110.981381 · Cited by 61
Short QT syndrome. Update on a recent entity.
Maury, P., Extramiana, F., Sbragia, P., Giustetto, C., Schimpf, R., Duparc, A., Wolpert, C., Denjoy, I., Delay, M., Borggrefe, M., et al. (2008) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2008.08.009 · Cited by 64
A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.
Moreno, C., Oliveras, A., de la Cruz, A., Bartolucci, C., Muñoz, C., Salar, E., Gimeno, J., Severi, S., Comes, N., Felipe, A., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv196 · Cited by 58
Homeostatic regulation of electrical excitability in physiological cardiac hypertrophy
Yang, K., Foeger, N. C., Marionneau, C., Jay, P. Y., McMullen, J. R., & Nerbonne, J. M. (2010) · The Journal of Physiology · doi:10.1113/jphysiol.2010.197418 · Cited by 60
Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology
Ehret, G., Desmeules, J. A., & Broers, B. (2007) · Expert Opinion on Drug Safety · doi:10.1517/14740338.6.3.289 · Cited by 58
Short QT Syndrome - Review of Diagnosis and Treatment.
Rudic, B., Schimpf, R., & Borggrefe, M. (2014) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2014.3.2.76 · Cited by 55
Drug therapy for atrial fibrillation: where do we go from here?
Page, R. L., & Roden, D. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1876 · Cited by 60
Short QT syndrome: The current evidences of diagnosis and management
Dewi, I., & Dharmadjati, B. (2020) · Journal of Arrhythmia · doi:10.1002/joa3.12439 · Cited by 49
Clinical use of antidepressant therapy and associated cardiovascular risk
Waring, W. S. (2012) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s28804 · Cited by 58
PD-118057 contacts the pore helix of hERG1 channels to attenuate inactivation and enhance K + conductance
Perry, M., Sachse, F. B., Abbruzzese, J., & Sanguinetti, M. C. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906597106 · Cited by 57
In vivo Effects of Mutant HERG K+ Channel Inhibition by Disopyramide in Patients with a Short QT‐1 Syndrome: A Pilot Study
Schimpf, R., Veltmann, C., Giustetto, C., Gaïta, F., Borggrefe, M., & Wolpert, C. (2007) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.00925.x · Cited by 56
Inhibition of the HERG potassium channel by the tricyclic antidepressant doxepin
Duncan, R. S., McPate, M. J., Ridley, J. M., Gao, Z., James, A. F., Leishman, D. J., Leaney, J. L., Witchel, H. J., & Hancox, J. C. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.024 · Cited by 56
Modulation of Transmural Repolarization
Antzelevitch, C. N. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1341.028 · Cited by 54
The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome.
Hu, D., Li, Y., Zhang, J.-C., Pfeiffer, R., Gollob, M., Healey, J., Harrell, D. T., Makita, N., Abe, H., Sun, Y., et al. (2017) · JACC Clinical Electrophysiology · doi:10.1016/j.jacep.2016.11.013 · Cited by 53
T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome
Kanters, J. K., Fanoe, S., Larsen, L. A., Thomsen, P. E. B., Toft, E. S., & Christiansen, M. (2004) · Heart Rhythm · doi:10.1016/j.hrthm.2004.05.002 · Cited by 54
Lidocaine-Induced Brugada Syndrome Phenotype Linked to a Novel Double Mutation in the Cardiac Sodium Channel
Barajas-Martínez, H., Hu, D., Cordeiro, J. M., Wu, Y., Kovacs, R. J., Meltser, H., Hong, K., Burashnikov, E., Brugada, R., Antzelevitch, C. N., et al. (2008) · Circulation Research · doi:10.1161/circresaha.108.172619 · Cited by 55
A novel KCNH2 mutation as a modifier for short QT interval.
Itoh, H., Sakaguchi, T., Ashihara, T., Ding, W.-G., Nagaoka, I., Oka, Y., Nakazawa, Y., Yao, T., Jo, H., Ito, M., et al. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.05.050 · Cited by 61
Common Genetic Variants, QT Interval, and Sudden Cardiac Death in a Finnish Population-Based Study
Noseworthy, P. A., Havulinna, A. S., Porthan, K., Lahtinen, A. M., Jula, A., Karhunen, P. J., Perola, M., Oikarinen, L., KONTULA, K. K., Salomaa, V. V., et al. (2011) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.110.959049 · Cited by 52
In silico study of action potential and QT interval shortening due to loss of inactivation of the cardiac rapid delayed rectifier potassium current
Zhang, H., & Hancox, J. C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.07.176 · Cited by 53
Pharmacogenomics and Acquired Long QT Syndrome
Aerssens, J., & Paulussen, A. D. C. (2005) · Pharmacogenomics · doi:10.1517/14622416.6.3.259 · Cited by 51
Short QT Syndrome
Bjerregaard, P., & Gussak, I. B. (2005) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2005.00064.x · Cited by 52
Functional evolution of Erg potassium channel gating reveals an ancient origin for I Kr
Martinson, A. S., van Rossum, D. B., Diatta, F. H., Layden, M. J., Rhodes, S. A., Martindale, M. Q., & Jegla, T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321716111 · Cited by 51
Channelopathies: Brugada syndrome, long QT syndrome, short QT syndrome, and CPVT
Schimpf, R., Veltmann, C., Wolpert, C., & Borggrefe, M. (2009) · Herz Kardiovaskuläre Erkrankungen · doi:10.1007/s00059-009-3238-1 · Cited by 49
Prevalence of Supraventricular Tachyarrhythmias in a Cohort of 115 Patients with Brugada Syndrome
Schimpf, R., Giustetto, C., Eckardt, L., Veltmann, C., Wolpert, C., Gaïta, F., Breithardt, G., & Borggrefe, M. (2008) · Annals of Noninvasive Electrocardiology · doi:10.1111/j.1542-474x.2008.00230.x · Cited by 51
Ventricular arrhythmogenesis: Insights from murine models
Sabir, I. N., Killeen, M. J., Grace, A. A., & Huang, C. L.-H. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2008.10.011 · Cited by 51
Malignant Perinatal Variant of Long-QT Syndrome Caused by a Profoundly Dysfunctional Cardiac Sodium Channel
Wang, D. W., Crotti, L., Shimizu, W., Pedrazzini, M., Cantù, F., Filippo, P. D., Kishiki, K., Miyazaki, A., Ikeda, T., Schwartz, P. J., et al. (2008) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.108.788349 · Cited by 51
Heritable arrhythmias associated with abnormal function of cardiac potassium channels
Crotti, L., Odening, K. E., & Sanguinetti, M. C. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa068 · Cited by 51
Targeting of Potassium Channels in Cardiac Arrhythmias
Burg, S., & Attali, B. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.03.005 · Cited by 51
Sudden Cardiac Death and Inherited Arrhythmia Syndromes
Sarkozy, A., & Brugada, P. (2005) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2005.50110.x · Cited by 51
Human ether-a-go-go-related (HERG) gene and ATP-sensitive potassium channels as targets for adverse drug effects
Zünkler, B. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.03.002 · Cited by 52
Transgenic short-QT syndrome 1 rabbits mimic the human disease phenotype with QT/action potential duration shortening in the atria and ventricles and increased ventricular tachycardia/ventricular fibrillation inducibility
Odening, K. E., Bódi, I., Franke, G., Rieke, R., de Medeiros, A. R., Perez‐Feliz, S., Fürniss, H. E., Mettke, L., Michaelides, K., Lang, C. N., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy761 · Cited by 50
In silico investigation of the short QT syndrome, using human ventricle models incorporating electromechanical coupling
Adeniran, I., Hancox, J., & Zhang, H.-G. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00166 · Cited by 45
Drug induced shortening of the QT/QTc interval: an emerging safety issue warranting further modelling and evaluation in drug research and development?
Holbrook, M., Malik, M., Shah, R., & Valentin, J. (2009) · Journal of pharmacological and toxicological methods · doi:10.1016/j.vascn.2008.09.001 · Cited by 40
Genetics of ion-channel disorders
Cerrone, M., Napolitano, C., & Priori, S. G. (2012) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328352429d · Cited by 49
Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
Du, C., Zhang, Y., Harchi, A. E., Dempsey, C. E., & Hancox, J. C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.05.013 · Cited by 49
Short QT Syndrome: A Comprehensive Genetic Interpretation and Clinical Translation of Rare Variants
Campuzano, Ó., Fernández-Falgueras, A., Lemus, X., Sarquella-Brugada, G., César, S., Coll, M., Matés, J., Arbelo, E., Jordà, P., Pérez-Serra, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8071035 · Cited by 38
Channelopathies: a New Category of Diseases Causing Sudden Death
Brugada, J., Brugada, R., & Brugada, P. (2007) · Herz · doi:10.1007/s00059-007-2976-1 · Cited by 48
A Major Role for hERG in Determining Frequency of Reentry in Neonatal Rat Ventricular Myocyte Monolayer
Hou, L., Deo, M., Furspan, P., Pandit, S. V., Mironov, S. F., Auerbach, D. S., Gong, Q., Zhou, Z., Berenfeld, O., & Jalife, J. (2010) · Circulation Research · doi:10.1161/circresaha.110.232470 · Cited by 48
Sudden infant death syndrome and inherited cardiac conditions
Baruteau, A., Tester, D. J., Kapplinger, J. D., Ackerman, M. J., & Behr, E. R. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.129 · Cited by 48
Pharmacology of Cardiac Potassium Channels
Li, G., & Dong, M. (2010) · Advances in pharmacology · doi:10.1016/s1054-3589(10)59004-5 · Cited by 48
Cardiac Ion Channelopathies and the Sudden Infant Death Syndrome
Wilders, R. (2012) · ISRN Cardiology · doi:10.5402/2012/846171 · Cited by 48
Emerging therapeutic targets in the short QT syndrome
Hancox, J., Whittaker, D. G., Du, C., Stuart, A. G., & Zhang, H.-G. (2018) · Expert opinion on therapeutic targets · doi:10.1080/14728222.2018.1470621 · Cited by 48
Susceptibility genes and modifiers for cardiac arrhythmias
Kääb, S., & Schulze‐Bahr, E. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.04.005 · Cited by 47
Origin and functional diversification of PAS domain, a ubiquitous intracellular sensor
Xing, J., Gumerov, V. M., & Zhulin, I. B. (2023) · Science Advances · doi:10.1126/sciadv.adi4517 · Cited by 44
hERG1 channel activators: a new anti-arrhythmic principle.
Grunnet, M., Hansen, R., & Olesen, S. (2008) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2009.01.002 · Cited by 53
Gain‐of‐Function KCNH2 Mutations in Patients with Brugada Syndrome
Wang, Q., Ohno, S., Ding, W.-G., Fukuyama, M., Miyamoto, A., Itoh, H., Makiyama, T., Wu, J., BAI, J., Hasegawa, K., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12361 · Cited by 45
Cardiac Channelopathies and Sudden Infant Death Syndrome
Tfelt-Hansen, J., Winkel, B., Grunnet, M., & Jespersen, T. (2011) · The Cardiology · doi:10.1159/000329047 · Cited by 53
Pharmacological approach to the treatment of long and short QT syndromes
Patel, C., & Antzelevitch, C. N. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.02.001 · Cited by 45
In Vivo Base Editing of Scn5a Rescues Type 3 Long QT Syndrome in Mice
Qi, M., Ma, S., Liu, J., Liu, X., Wei, J., Lu, W., Zhang, S., Chang, Y., Zhang, Y., Zhong, K., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065624 · Cited by 46
Short QT Syndrome: A Review
Patel, U., & Pavri, B. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181c07592 · Cited by 26
Concomitant Brugada-like and short QT electrocardiogram linked to SCN5A mutation
Hong, K., Hu, J.-Z., Yu, J.-H., Cheng, X.-S., & Brugada, R. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.63 · Cited by 40
Cardiac Ion Channel Regulation in Obesity and the Metabolic Syndrome: Relevance to Long QT Syndrome and Atrial Fibrillation
Aromolaran, A. S., & Boutjdir, M. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00431 · Cited by 44
Long QT syndrome and short QT syndrome: how to make correct diagnosis and what about eligibility for sports activity
Napolitano, C., Bloise, R., & Priori, S. G. (2006) · Journal of Cardiovascular Medicine · doi:10.2459/01.jcm.0000219317.12504.5f · Cited by 44
Nifekalant and Disopyramide in a Patient with Short QT Syndrome: Evaluation of Pharmacological Effects and Electrophysiological Properties
Mizobuchi, M., Enjoji, Y., Yamamoto, R., Ono, T., Funatsu, A., Kambayashi, D., Kobayashi, T., & Nakamura, S. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01169.x · Cited by 44
Decreases in Electrocardiographic R-Wave Amplitude and QT Interval Predict Myocardial Ischemic Infarction in Rhesus Monkeys with Left Anterior Descending Artery Ligation
Sun, X., Cai, J., Fan, X., Han, P., Xie, Y., Chen, J.-M., Xiao, Y.-B., & Kang, Y. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071876 · Cited by 47
Modelling of short QT syndrome in a heterogeneous model of the human ventricular wall
Weiss, D. L., Seemann, G., Sachse, F. B., & Dössel, O. (2005) · EP Europace · doi:10.1016/j.eupc.2005.04.008 · Cited by 43
Cardiac and Autonomic Mechanisms Contributing to SUDEP
Bermeo-Ovalle, A. C., Kennedy, J. D., & Schuele, S. (2015) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000155 · Cited by 43
Comparative effects of the short QT N588K mutation at 37 degrees C on hERG K+ channel current during ventricular, Purkinje fibre and atrial action potentials: an action potential clamp study.
McPate, M. J., Zhang, H., Adeniran, I., Cordeiro, J. M., Witchel, H., & Hancox, J. C. (2009) · PubMed · Cited by 43
European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on risk assessment in cardiac arrhythmias: use the right tool for the right outcome, in the right population
Nielsen, J. C., Lin, Y., Figueiredo, M. J. D. O., Shamloo, A. S., Alfie, A., Bovéda, S., Dagres, N., Toro, D. D., Eckhardt, L. L., Ellenbogen, K. A., et al. (2020) · Heart Rhythm · doi:10.1016/j.hrthm.2020.05.004 · Cited by 42
Arrhythmic potency of human ether-à-go-go-related gene mutations L532P and N588K in a computational model of human atrial myocytes
Loewe, A., Wilhelms, M., Fischer, F., Scholz, E. P., Dössel, O., & Seemann, G. (2014) · EP Europace · doi:10.1093/europace/eut375 · Cited by 42
Short QT interval in clinical practice.
Bjerregaard, P., Nallapaneni, H., & Gussak, I. (2010) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2010.06.004 · Cited by 40
Atrial fibrillation: evidence for genetically determined disease
Andalib, A., Brugada, R., & Nattel, S. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282fa7142 · Cited by 41
The short QT syndrome
Hancox, J., McPate, M., Harchi, A. E. L., Duncan, R. S., Dempsey, C., Witchel, H. J., Adeniran, I., & Zhang, H.-G. (2011) · Journal of interventional cardiac electrophysiology · doi:10.1007/s10840-011-9566-0 · Cited by 29
Sudden death in epilepsy: the overlap between cardiac and neurological factors
Shlobin, N. A., Thijs, R. D., Benditt, D. G., Zeppenfeld, K., & Sander, J. W. A. S. (2024) · Brain Communications · doi:10.1093/braincomms/fcae309 · Cited by 43
New echocardiographic insights in short QT syndrome: More than a channelopathy?
Frea, S., Giustetto, C., Capriolo, M., Scrocco, C., Fornengo, C., Benedetto, S., Bianchi, F., Pidello, S., Morello, M., & Gaïta, F. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.05.024 · Cited by 41
Repolarization of the cardiac action potential. Does an increase in repolarization capacity constitute a new anti‐arrhythmic principle?
Grunnet, M. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.02072.x · Cited by 43
Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies
Magi, S., Lariccia, V., Maiolino, M., Amoroso, S., & Gratteri, S. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0364-6 · Cited by 46
Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints
Liu, M., Zhang, L., Li, S., Yang, T., Liu, L., Zhao, J. H., & Liu, H. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.07.003 · Cited by 43
The action of the novel gastrointestinal prokinetic prucalopride on the HERG K+ channel and the common T897 polymorph
Chapman, H., & Pasternack, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.10.019 · Cited by 41
Genética y arritmias: aplicaciones diagnósticas y pronósticas
Monteforte, N., Napolitano, C., & Priori, S. G. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.10.008 · Cited by 39
Digitalis Administration: An Underappreciated but Common Cause of Short QT Interval
Cheng, T. O. (2004) · Circulation · doi:10.1161/01.cir.0000118177.56908.5b · Cited by 40
Pro‐arrhythmogenic effects of the S140G KCNQ1 mutation in human atrial fibrillation – insights from modelling
Kharche, S., Adeniran, I., Stott, J., Law, P., Boyett, M. R., Hancox, J. C., & Zhang, H. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.229146 · Cited by 39
Probing the Binding Sites and Mechanisms of Action of Two Human Ether-a-go-go-Related Gene Channel Activators, 1,3-bis-(2-Hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)
Xu, X., Recanatini, M., Roberti, M., & Tseng, G. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.045591 · Cited by 40
Nedd4-2-dependent ubiquitylation and regulation of the cardiac potassium channel hERG1
Albesa, M., Grilo, L. S., Gavillet, B., & Abriel, H. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.03.015 · Cited by 39
Molecular Determinants for Activation of Human Ether-à-go-go-related Gene 1 Potassium Channels by 3-Nitro-N-(4-phenoxyphenyl) Benzamide
Garg, V., Stary‐Weinzinger, A., Sachse, F. B., & Sanguinetti, M. C. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.073809 · Cited by 39
Clinical characteristics and treatment of short QT syndrome
Wolpert, C., Schimpf, R., Veltmann, C., Giustetto, C., Gaïta, F., & Borggrefe, M. M. (2005) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.3.4.611 · Cited by 42
Ion Channels in the Heart
Bartos, D. C., Grandi, E., & Ripplinger, C. M. (2015) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2015.tb00647.x · Cited by 178
Spatial gradients in action potential duration created by regional magnetofection of hERG are a substrate for wavebreak and turbulent propagation in cardiomyocyte monolayers
Campbell, K. F., Calvo, C. J., Mironov, S. F., Herron, T. J., Berenfeld, O., & Jalife, J. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238758 · Cited by 36
Atrial fibrillation in inherited cardiac channelopathies: From mechanisms to management.
Enriquez, A., Antzelevitch, C., Bismah, V., & Baranchuk, A. (2016) · Heart Rhythm · doi:10.1016/j.hrthm.2016.06.008 · Cited by 38
The new kids on the block of arrhythmogenic disorders: Short QT syndrome and early repolarization
Mazzanti, A., Underwood, K., Nevelev, D., Kofman, S., & Priori, S. (2017) · Cardiovascular Electrophysiology · doi:10.1111/jce.13265 · Cited by 32
Is acquired short QT due to digitalis intoxication responsible for malignant venticular arrhythmias?
Garberoglio, L., Giustetto, C., Wolpert, C., & Gaïta, F. (2006) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2006.07.003 · Cited by 38
The hERG K+ channel S4 domain L532P mutation: Characterization at 37°C
Zhang, Y. H., Colenso, C. K., Sessions, R. B., Dempsey, C. E., & Hancox, J. C. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.07.001 · Cited by 38
Genetics of familial atrial fibrillation
Campuzano, Ó., & Brugada, R. (2009) · EP Europace · doi:10.1093/europace/eup199 · Cited by 37
Cardiac Repolarisation and Drug Regulation
Shah, R. R. (2007) · Drug Safety · doi:10.2165/00002018-200730120-00003 · Cited by 38
I Kr Impact on Repolarization and Its Variability Assessed by Dynamic Clamp
Altomare, C., Bartolucci, C., Sala, L., Bernardi, J., Mostacciuolo, G., Rocchetti, M., Severi, S., & Zaza, A. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.002572 · Cited by 38
Genetics of channelopathies associated with sudden cardiac death
Campuzano, Ó., Sarquella‐Brugada, G., Brugada, R., & Brugada, J. (2015) · Global Cardiology Science and Practice · doi:10.5339/gcsp.2015.39 · Cited by 36
Clinical and electrocardiographic characteristics of patients with short QT interval in a large hospital-based population.
Miyamoto, A., Hayashi, H., Yoshino, T., Kawaguchi, T., Taniguchi, A., Itoh, H., Sugimoto, Y., Itoh, M., Makiyama, T., Xue, J. Q., et al. (2012) · Heart Rhythm · doi:10.1016/j.hrthm.2011.08.016 · Cited by 36
Ranolazine and Vernakalant Prevent Ventricular Arrhythmias in an Experimental Whole‐Heart Model of Short QT Syndrome
Frommeyer, G., Ellermann, C., Dechering, D. G., Kochhäuser, S., Bögeholz, N., Güner, F., Leitz, P. R., Pott, C., & Eckardt, L. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13029 · Cited by 35
Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism
Frolov, R. V., Ignatova, I. I., & Singh, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026344 · Cited by 35
IK1 modulates the U-wave: insights in a 100-year-old enigma
Postema, P. G., van Eck, H. J. R., Tobias Opthof, A., van Herpen, G., van Dessel, P. F. H. M., Priori, S. G., Wolpert, C., Borggrefe, M., Kors, J. A., & Wilde, A. A. M. (2008) · Heart Rhythm · doi:10.1016/j.hrthm.2008.11.024 · Cited by 34
Kcnh1 Voltage-gated Potassium Channels Are Essential for Early Zebrafish Development
Stengel, R., Rivera‐Milla, E., Sahoo, N., Ebert, C., Bollig, F., Heinemann, S. H., Schönherr, R., & Englert, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363978 · Cited by 34
PQ Segment Depression in Short QT Syndrome Patients: A Novel Marker for Diagnosing Short QT Syndrome?
Tülümen, E., Giustetto, C., Wolpert, C., Maury, P., Anttonen, O., Probst, V., Blanc, J., Sbragia, P., Scrocco, C., Rudic, B., et al. (2014) · Heart Rhythm · doi:10.1016/j.hrthm.2014.02.024 · Cited by 33
Computational Analysis of the Mode of Action of Disopyramide and Quinidine on hERG-Linked Short QT Syndrome in Human Ventricles
Whittaker, D. J., Ni, H., Benson, A. P., Hancox, J. C., & Zhang, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00759 · Cited by 34
Role of Ca2+ in healthy and pathologic cardiac function: from normal excitation–contraction coupling to mutations that cause inherited arrhythmia
Keefe, J. A., Moore, O. M., Ho, K. S., & Wehrens, X. H. T. (2022) · Archives of Toxicology · doi:10.1007/s00204-022-03385-0 · Cited by 32
Cardiac Causes of Sudden Unexpected Death in Children and Their Relationship to Seizures and Syncope: Genetic Testing for Cardiac Electropathies
Ackerman, M. J. (2005) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2005.02.002 · Cited by 35
Clinical Management of Ventricular Tachycardia
Pellegrini, C. N., & Scheinman, M. M. (2010) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2010.08.001 · Cited by 33
Genetics of sudden cardiac death in children and young athletes
Sarquella‐Brugada, G., Campuzano, Ó., Iglesias, A., Sánchez-Malagón, J., Guerra-Balic, M., Brugada, J., & Brugada, R. (2012) · Cardiology in the Young · doi:10.1017/s1047951112001138 · Cited by 36
2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic Acid (PD-307243) Causes Instantaneous Current through Human Ether-a-go-go-Related Gene Potassium Channels
Gordon, E., Lozinskaya, I. M., Lin, Z., Semus, S. F., Blaney, F. E., Willette, R. N., & Xu, X. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.041152 · Cited by 34
The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation
Cerrone, M., Noujaim, S. F., & Jalife, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01582.x · Cited by 34
Gene mutations in cardiac arrhythmias: a review of recent evidence in ion channelopathies
Sung, R. J., Hsiao, Tien, Lo, C., Juang, J. J., & Wang, Y.-H. (2013) · The Application of Clinical Genetics · doi:10.2147/tacg.s29676 · Cited by 34

Authors: Brugada, R., Hong, K., Dumaine, R., Cordeiro, J., Gaita, F., Borggrefe, M., Menendez, T. M., Brugada, J., Pollevick, G. D., Wolpert, C., Burashnikov, E., Matsuo, K., Sheng Wu, Y., Guerchicoff, A., Bianchi, F., Giustetto, C., Schimpf, R., Brugada, P., & Antzelevitch, C.
Affiliations: From the Molecular Genetics (R.B., K.H., G.D.P., E.B., K.M., A.G.), Molecular Biology (R.D., Y.S.W.), and Experimental Cardiology (J.C., C.A.) Programs, Masonic Medical Research Laboratory, Utica, NY; Division of Cardiology (F.G., F.B., C.G.), Ospedale Mauriziano Umberto I, Torino, Italy; First Department of Medicine (M.B., C.W., R.S.), University Hospital Mannheim, University of Heidelberg, Mannheim, Germany; North Texas Heart Center (T.M.M.), Dallas, Tex; Arrhythmia Section (J.B.), Cardiovascular...
Heidelberg University (DE)
ORCID: Hong, Kui
Dumaine, Robert
Cordeiro, Jonathan
Borggrefe, Martin
Guerchicoff, Alejandra
Giustetto, Carla
Brugada, Pedro
Antzelevitch, Charles
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-01-06
Volume: 109
Issue: 1
Pages: 30-35
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000109482.92774.3a
OpenAlex: W2129393568
Cited by: 847
References: 27
Citations by year: 2026: 6 · 2025: 15 · 2024: 22 · 2023: 16 · 2022: 14 · 2021: 25 · 2020: 31 · 2019: 22 · 2018: 29 · 2017: 48 · 2016: 29 · 2015: 28 · 2014: 35 · 2013: 48 · 2012: 58
FWCI: 31.40
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: sudden cardiac death, short QT syndrome, hERG, KCNH2, gain-of-function mutations, ventricular arrhythmias, action potential duration, sudden infant death syndrome, drug interactions, hereditary arrhythmia
MeSH terms: ERG1 Potassium Channel, Adult, Arrhythmias, Cardiac, Cell Line, Electrocardiography, Female, Humans, Infant, Ion Channels, Male, Middle Aged, Syndrome, Death, Sudden, Cardiac, Genetic Heterogeneity, Mutation, Missense, Potassium Channels, Voltage-Gated, Ether-A-Go-Go Potassium Channels

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks